Clinical Trial: A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)

U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07338786) titled 'A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)' on Jan. 04.

Brief Summary: This clinical trial employed a single-center, open-label, single-arm design. A total of 80 participants aged 10 to 60 years were enrolled and divided into two age groups: 40 in the 18-60 years cohort and 40 in the 10-17 years cohort. All participants received the lyophilized human rabies vaccine (human diploid cell)

Study Start Date: Sept. 13, 2025

Study Type: INTERVENTIONAL

Condition: RabiesPrevention

Intervention: DRUG: Lyophilized Human Rabies Vaccine (Hum...